TITLE II—INCREASING AWARE-
NESS OF PULMONARY HYPER-
TENSION 
SEC. 201. PROMOTING PUBLIC AWARENESS. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall carry out an educational campaign to increase 
public awareness of pulmonary hypertension. Print, video, 
and Web-based materials distributed under this program 
may include— 
(1) basic information on pulmonary hyper-
tension and its symptoms; and 
(2) information on— 
(A) the incidence and prevalence of pul-
monary hypertension; 
(B) diseases and conditions that can lead 
to pulmonary hypertension as a secondary diag-
nosis; 
(C) the importance of early diagnosis; and 
(D) the availability, as medically appro-
priate, of a range of treatment options and pul-
monary hypertension. 
(b) DISSEMINATION
OF INFORMATION.—The Sec-
retary is encouraged to disseminate information under 
subsection (a) through a cooperative agreement with a na-
VerDate Mar 15 2010 
06:06 May 12, 2011
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1810.IH
H1810
pwalker on DSKD5P82C1PROD with BILLS
tional nonprofit entity with expertise in pulmonary hyper-
tension. 
(c) REPORT TO CONGRESS.—Not later than Sep-
tember 30, 2012, the Secretary shall report to the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives, the Committee on Health, Education, Labor, 
and Pensions of the Senate, and the Committees on Ap-
propriations of the House of Representatives and the Sen-
ate on the status of activities under this section. 
(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $2,500,000 for each of fiscal years 
2012, 2013, and 2014. 
SEC. 202. PROMOTING AWARENESS AMONG HEALTH CARE 
PROFESSIONALS. 
(a) IN GENERAL.—The Secretary, acting through the 
Administrator of the Health Resources and Services Ad-
ministration and the Director of the Centers for Disease 
Control and Prevention, shall carry out an educational 
campaign to increase awareness of pulmonary hyper-
tension among health care providers. Print, video, and 
Web-based materials distributed under this program may 
include information on— 
(1) the symptoms of pulmonary hypertension; 
(2) the importance of early diagnosis; 
VerDate Mar 15 2010 
06:06 May 12, 2011
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1810.IH
H1810
pwalker on DSKD5P82C1PROD with BILLS
(3) current diagnostic criteria; and 
(4) Food and Drug Administration-approved 
therapies for the disease. 
(b) TARGETED HEALTH CARE PROVIDERS.—Health 
care providers targeted through the campaign under sub-
section (a) shall include, but not be limited to, cardiolo-
gists, pulmonologists, rheumatologists, primary care phy-
sicians, pediatricians, and nurse practitioners. 
(c) DISSEMINATION
OF INFORMATION.—The Sec-
retary is encouraged to disseminate information under 
subsection (a) through a cooperative agreement with a na-
tional nonprofit entity with expertise in pulmonary hyper-
tension. 
(d) REPORT TO CONGRESS.—Not later than Sep-
tember 30, 2012, the Secretary shall report to the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives, the Committee on Health, Education, Labor, 
and Pensions of the Senate, and the Committees on Ap-
propriations of the House of Representatives and the Sen-
ate on the status of activities under this section. 
(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $2,500,000 for each of fiscal years 
2012, 2013, and 2014. 
Æ 
VerDate Mar 15 2010 
06:06 May 12, 2011
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H1810.IH
H1810
pwalker on DSKD5P82C1PROD with BILLS